PPAR Research

PPARs in Viral Disease


Publishing date
01 Jan 2009
Status
Published
Submission deadline
01 Jul 2008

Lead Editor
Guest Editors

PPARs in Viral Disease

Articles

  • Special Issue
  • - Volume 2009
  • - Article ID 393408
  • - Editorial

PPARs in Viral Disease

Jacqueline Capeau | Lawrence Serfaty | Mostafa Badr
  • Special Issue
  • - Volume 2009
  • - Article ID 906167
  • - Review Article

PPAR and Liver Injury in HIV-Infected Patients

Maud Lemoine | Jacqueline Capeau | Lawrence Serfaty
  • Special Issue
  • - Volume 2009
  • - Article ID 145124
  • - Review Article

Peroxisome Proliferator-Activated Receptors in HBV-Related Infection

Laurent Dubuquoy | Alexandre Louvet | ... | Sébastien Dharancy
  • Special Issue
  • - Volume 2009
  • - Article ID 357204
  • - Review Article

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection

Sébastien Dharancy | Maud Lemoine | ... | Laurent Dubuquoy
  • Special Issue
  • - Volume 2009
  • - Article ID 421376
  • - Review Article

Is PPAR 𝛾 a Prospective Player in HIV-1-Associated Bone Disease?

Eoin J. Cotter | Patrick W. Mallon | Peter P. Doran
  • Special Issue
  • - Volume 2009
  • - Article ID 483485
  • - Review Article

Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance

Francesco Negro
  • Special Issue
  • - Volume 2009
  • - Article ID 507141
  • - Review Article

Antiretroviral-Related Adipocyte Dysfunction and Lipodystrophy in HIV-Infected Patients: Alteration of the PPAR -Dependent Pathways

Martine Caron | Corinne Vigouroux | ... | Jacqueline Capeau
  • Special Issue
  • - Volume 2009
  • - Article ID 607902
  • - Review Article

HIV-1 Infection and the PPAR -Dependent Control of Adipose Tissue Physiology

Marta Giralt | Pere Domingo | Francesc Villarroya
  • Special Issue
  • - Volume 2009
  • - Article ID 373524
  • - Review Article

The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients

Jussi Sutinen
PPAR Research
 Journal metrics
Acceptance rate44%
Submission to final decision48 days
Acceptance to publication38 days
CiteScore7.100
Impact Factor2.953
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.